The maximum recommended dose of Ajaduo 25 mg/5 mg Tablet (empagliflozin 25 mg/linagliptin 5 mg) is one tablet once daily, as confirmed in clinical trials and guidelines for the fixed-dose combination, where empagliflozin is capped at 25 mg daily and linagliptin at 5 mg daily. Exceeding this risks overdose, hypoglycemia, dehydration, or other side effects like ketoacidosis. Dosage must follow a healthcare provider's prescription, adjusted for factors like renal function (e.g., eGFR), glycemic response, and tolerability.